glp-1 receptor agonists in pediatric and adolescent obesity Management of Childhood GLP-1 Receptor Agonists for Obesity
Description
doi: 10.1007/s00125-006-0510-2
Henderson BE, Lee NH, Seewaldt V, Shen H
Weight loss continues at a steady pace during month 3
Thus, creating a void to conduct future studies to examine longer duration treatment to check their prolonged effects (98)
T., Yao, W
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes
